Congenital Deficiency in Plasma Kallikrein and Kininogens in the Brown Norway Rat

Overview

Journal Experientia

Specialty Science

Date 1980 May 15

PMID 6900563

Citations 14

Authors

J Damas

A Adam

Affiliations

Soon will be listed here.

Abstract

The kallikrein-kininogens-kinins system has been investigated in the brown Norway rat. In this breed the stores of kininogens in the plasma are reduced and the plasma kallikrein-like activity appears to be absent both in vivo and in vitro.

Citing Articles

A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Katori M, Majima M Pharmaceuticals (Basel). 2016; 3(1):59-109.

PMID: 27713243 PMC: 3991021. DOI: 10.3390/ph3010059.

Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system.

Sridharan V, Tripathi P, Sharma S, Moros E, Corry P, Lieblong B Cancer Res. 2012; 72(19):4984-92.

PMID: 22865451 PMC: 3463770. DOI: 10.1158/0008-5472.CAN-12-1831.

Experimental radiation-induced heart disease: past, present, and future.

Boerma M Radiat Res. 2012; 178(1):1-6.

PMID: 22663150 PMC: 3423081. DOI: 10.1667/rr2933.1.

Potentiation of the pro-inflammatory effects of bradykinin by inhibition of angiotensin-converting enzyme and aminopeptidase P in rat paws.

Damas J, Liegeois J, SIMMONS W Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(5):670-6.

PMID: 8938668 DOI: 10.1007/BF00170844.

Influence of several peptidase inhibitors on the pro-inflammatory effects of substance P, capsaicin and collagenase.

Damas J, Bourdon V, Liegeois J, SIMMONS W Naunyn Schmiedebergs Arch Pharmacol. 1996; 354(5):662-9.

PMID: 8938667 DOI: 10.1007/BF00170843.

References

Ratnoff O, Rosenblum J . Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. Am J Med. 1958; 25(2):160-8. DOI: 10.1016/0002-9343(58)90023-8. View

DONALDSON V, Glueck H, Miller M, Movat H, Habal F . Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. J Lab Clin Med. 1976; 87(2):327-37. View

Colman R, Bagdasarian A, TALAMO R, Scott C, Seavey M, Guimaraes J . Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest. 1975; 56(6):1650-62. PMC: 333144. DOI: 10.1172/JCI108247. View

Gautvik K . Kininogen in plasma from cat, hamster and guinea-pig. Acta Physiol Scand. 1969; 76(1):191-200. DOI: 10.1111/j.1748-1716.1969.tb04463.x. View

Ratnoff O, CRUM J . ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID. J Lab Clin Med. 1964; 63:359-77. View

Hathaway W, BELHASEN L, HATHAWAY H . Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties. Blood. 1965; 26(5):521-32. View

Ratnoff O . Mediators of inflammation. J Allergy Clin Immunol. 1976; 58(3):438-46. DOI: 10.1016/0091-6749(76)90125-1. View

Schwartz H, KELLERMEYER R . Carrageenan and delayed hypersensitivity. II. Activation of Hageman factor by carrageenan and its possible significance. Proc Soc Exp Biol Med. 1969; 132(3):1021-4. DOI: 10.3181/00379727-132-34358. View

Erdos E . The kinins. A status report. Biochem Pharmacol. 1976; 25(14):1563-9. DOI: 10.1016/0006-2952(76)90465-2. View

10.

Ratnoff O, Davie E, MALLETT D . Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest. 1961; 40:803-19. PMC: 290792. DOI: 10.1172/JCI104314. View

11.

DINIZ C, Carvalho I . A micromethod for determination of bradykininogen under several conditions. Ann N Y Acad Sci. 1963; 104:77-89. DOI: 10.1111/j.1749-6632.1963.tb17654.x. View

12.

Damas J . [On the hypotensive activity of carrageenan iota in the rat (author's transl)]. Pathol Biol (Paris). 1978; 26(3-4):153-8. View

13.

LECOMTE J . [On the kininogens of rat plasma]. Arch Int Pharmacodyn Ther. 1968; 173(2):495-6. View

14.

Wuepper K, Miller D, Lacombe M . Flaujeac trait. Deficiency of human plasma kininogen. J Clin Invest. 1975; 56(6):1663-72. PMC: 333145. DOI: 10.1172/JCI108248. View

15.

Jacobsen S . Substrates for plasma kinin-forming enzymes in rat and guinea-pig plasma. Br J Pharmacol Chemother. 1966; 28(1):64-72. PMC: 1510843. DOI: 10.1111/j.1476-5381.1966.tb01874.x. View

16.

Saito H, Ratnoff O, Waldmann R, Abraham J . Fitzgerald Trait: Deficiency of a Hitherto Unrecognized Agent, Fitzgerald Factor, Participating in Surface-Mediated Reactions of Clotting, Fibrinolysis, Generation of Kinins, and the Property of Diluted Plasma Enhancing Vascular Permeability (PF/Dil). J Clin Invest. 1975; 55(5):1082-9. PMC: 301855. DOI: 10.1172/JCI108009. View

17.

Wuepper K . Prekallikrein deficiency in man. J Exp Med. 1973; 138(6):1345-55. PMC: 2139450. DOI: 10.1084/jem.138.6.1345. View

18.

Gautvik K, Rugstad H . Kinin formation and kininogen depletion in rats after intravenous injection of ellagic acid. Br J Pharmacol Chemother. 1967; 31(3):390-400. PMC: 1557345. DOI: 10.1111/j.1476-5381.1967.tb00406.x. View

19.

LECOMTE J, Damas J . [On the role of kininogens in the syndrome released by dextrans in the rat]. Arch Int Pharmacodyn Ther. 1968; 176(2):403-17. View

20.

Margolis J . Activation of plasma by contact with glass: evidence for a common reaction which releases plasma kinin and initiates coagulation. J Physiol. 1958; 144(1):1-22. PMC: 1356767. DOI: 10.1113/jphysiol.1958.sp006082. View